Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Knifsend Robin — CytomX Therapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Knifsend Robin

Knifsend Robin

Principal Accounting Officer at CytomX Therapeutics, Inc. · on record since May 31, 2019

Insider trading activity of Knifsend Robin

Transactions on record: 2; since Jun 4, 2019

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Feb 21, 2020

Figures computed from official regulatory filings — methodology.

Companies where Knifsend Robin has traded

CytomX Therapeutics, Inc.2 tx · $14.9K · Feb 21, 2020

Track record of Knifsend Robin

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Knifsend Robin

Co-insiders of Knifsend Robin

Ashworth AlanCytomX Therapeutics, Inc.
BELVIN MARCIACytomX Therapeutics, Inc.
BIOTECHNOLOGY VALUE FUND II LPCytomX Therapeutics, Inc.
BIOTECHNOLOGY VALUE FUND L PCytomX Therapeutics, Inc.
Biotechnology Value Trading Fund OS LPCytomX Therapeutics, Inc.
BVF GP HOLDINGS LLCCytomX Therapeutics, Inc.
BVF I GP LLCCytomX Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

BVF II GP LLCCytomX Therapeutics, Inc.

BVF INC/ILCytomX Therapeutics, Inc.

BVF PARTNERS L P/ILCytomX Therapeutics, Inc.

BVF Partners OS Ltd.CytomX Therapeutics, Inc.

Campoy CarlosCytomX Therapeutics, Inc.

Canaan IX L.P.CytomX Therapeutics, Inc.

Canaan Partners IX LLCCytomX Therapeutics, Inc.

Chu Yu-WayeCytomX Therapeutics, Inc.

Exter NeilCytomX Therapeutics, Inc.

Fuchs Charles S.CytomX Therapeutics, Inc.

Gilbert Halley ECytomX Therapeutics, Inc.

GLUCK FREDERICK WCytomX Therapeutics, Inc.

Goeltz II Robert C.CytomX Therapeutics, Inc.

Hadley Harbor Master Investors (Cayman) L.P.CytomX Therapeutics, Inc.

HANNAH ALISON L.CytomX Therapeutics, Inc.

Huh HoyoungCytomX Therapeutics, Inc.

HUMPHREY RACHELCytomX Therapeutics, Inc.

Jones Elaine VCytomX Therapeutics, Inc.

Kavanaugh William MichaelCytomX Therapeutics, Inc.

LADD CYNTHIA JCytomX Therapeutics, Inc.

LAMPERT MARK NCytomX Therapeutics, Inc.

Landau Jeffrey BCytomX Therapeutics, Inc.

Lester RachaelCytomX Therapeutics, Inc.

LEVIN MARK JCytomX Therapeutics, Inc.

McCarthy Sean A.CytomX Therapeutics, Inc.

McCourt MarionCytomX Therapeutics, Inc.

Meyers James RCytomX Therapeutics, Inc.

Mohindru ManiCytomX Therapeutics, Inc.

Ogden ChristopherCytomX Therapeutics, Inc.

Peterson Amy C.CytomX Therapeutics, Inc.

RAY DEBANJANCytomX Therapeutics, Inc.

ROWLAND LLOYD ACytomX Therapeutics, Inc.

SCARLETT JOHN ACytomX Therapeutics, Inc.

SHANNON TIMOTHY MCytomX Therapeutics, Inc.

STARR KEVIN PCytomX Therapeutics, Inc.

Su ZhenCytomX Therapeutics, Inc.

TEPPER ROBERT ICytomX Therapeutics, Inc.

Third Rock Ventures GP, L.P.CytomX Therapeutics, Inc.

THIRD ROCK VENTURES LPCytomX Therapeutics, Inc.

TRV GP, LLCCytomX Therapeutics, Inc.

Young Matthew P.CytomX Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
CytomX Therapeutics, Inc.	Feb 21, 2020	AwardD	34,000	0.00 USD	$0	SEC
CytomX Therapeutics, Inc.	Jun 4, 2019	Award	1,812	8.21 USD	$14.9K	SEC